SOURCE: Wall Street News Alert

Wall Street News Alert

February 17, 2010 09:33 ET

Wall Street News Alert: Breaking News Alert: Caleco Pharma Corp. -- February 17, 2010

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding.

WESTON, FL--(Marketwire - February 17, 2010) - Wall Street News Alert's "stocks to watch" this morning are: Caleco Pharma Corp. (OTCBB: CAEH), Apple Inc. (NASDAQ: AAPL), The Goldman Sachs Group, Inc. (NYSE: GS) and Citi (NYSE: C).

Caleco Pharma Corp. (OTCBB: CAEH), a biopharmaceutical and consumer health products company, issued a press release yesterday detailing new developments that are expected to unlock value in the Company's existing products, while simultaneously expanding its new product pipeline.

"Our corporate strategy is to identify products derived from plant extracts, naturally occurring oils and symbiotic pro-biotic systems for development as OTC supplements or as prescription medications. Maintaining in-house expertise to identify, develop and launch products via the OTC consumer health & wellness or ethical drug pathways provides us with the flexibility to maximize the market potential of individual products while offering Caleco Pharma Corp. multiple options for commercialization whether we partner, out-license or go to market alone.," said John Boschert, Caleco Pharma's President.

The company's press release also stated recent company advancements:

-- Retains experienced product development and sales executives
-- Signs Agreement with Natac Biotech S.L. to acquire eighteen
   percent (18%) of the share capital of Natac Biotech S.L.

In addition, Caleco will communicate new developments in expedited fashion. It has engaged firms to facilitate orderly markets for its stock, and provide market awareness for shareholders and new investors. Caleco has also engaged the services of BlueWater Advisory Group, LLC in the US, and Mr. Peter Kitzinski in Germany, to communicate the new developments to the international capital markets.

In closing, Mr. Boschert said, "These are very exciting times for our growing company. We have an innovative yet solid business plan in place that positions us very well in the rapidly expanding consumer health, wellness and, bio-pharmaceutical marketplaces. We have sought out and secured an aggressive and successful management team to build out the research, development, marketing and sales strategies of our existing and new products. We have formed an alliance with Natac, which we anticipate will assist us in the development of our products and in developing our product pipeline. We have strategically positioned ourselves in this exciting arena and we have in place the mechanism to communicate our successes to the investing public, thereby assisting us with access to capital and other potential strategic options for the company," concluded Mr. Boschert.

For additional details, please see the company's press release.

The stock closed yesterday at Twenty Seven cents a share.

For an in-depth profile of Caleco Pharma, visit http://www.wallstreetnewsalert.com/view-company-profiles.php?profile=CAEH_021610.

To receive FREE Mobile Stock Alerts formatted especially for your cell phone, text the word "press" in the subject line to 68494.

For more information, please visit www.WallStreetNewsAlert.com and you can also follow Wall Street News Alerts on Twitter at http://twitter.com/wsna

Apple Inc. (NASDAQ: AAPL) up 1.5% on 19.4 million shares traded.

Apple continues to lead the industry in innovation with its award-winning computers, OS X operating system and iLife and professional applications.

The Goldman Sachs Group, Inc. (NYSE: GS) up 2.5% on 11.5 million shares traded. The Goldman Sachs Group, Inc. is a leading global financial services firm providing investment banking, securities and investment management services to a substantial and diversified client base that includes corporations, financial institutions, governments and high-net-worth individuals.

Citi (NYSE: C) up 4% on 332.2 million shares traded.

Citi, the leading global financial services company, has approximately 200 million customer accounts and does business in more than 140 countries.

Market Commentary:

Bond prices edged higher as concerns about the Greek debt crisis began to wane. The yield on the benchmark 10-year Treasury note, which moves opposite its price, fell to 3.67 percent from 3.70 percent late Friday.

Let Wall Street News Alert help advertise for your company using our effective awareness campaigns. If you're Interested in telling your story, we can help. Contact us at info@wallstreetnewsalert.com

WSNA's email alert service is free to those investors who sign up on the WSNA home page. The alert service is designed to notify investors of often-overlooked stocks. Subscribers are introduced to Special Situation companies that have the potential of showing increased activity. The Wall Street News Alert home page has experienced over 200 million hits. To subscribe to this free service, visit the Wall Street News Alert home page at http://www.wallstreetnewsalert.com.

*** It has come to the attention of Wall Street News Alert (WSNA), that various persons or companies distribute faxes bearing similar names to Wall Street News Alert. Wall Street News Alert is not affiliated with faxes bearing names such as: Wall Street Stock Alert, Wall Street Investor Alert, Wall Street News Alert or any other fax using various combinations of the generic words Wall Street.***

Wall Street News Alert is a division of Wall Street Capital Funding LLC (WSCF). WSCF also maintains a contractual, working relationship with Stock Market Alerts LLC and its Wall Street Enews brand. WSCF is not a registered broker/dealer and may not sell, offer to sell or offer to buy any security. WSCF profiles are not a solicitation or recommendation to buy, sell or hold securities. An offer to buy or sell can be made only with accompanying disclosure documents from the company offering or selling securities and only in the states and provinces for which they are approved. The material in this release is intended to be strictly informational. The companies that are discussed in this release have not approved the statements made in this release nor approved the timing of this release. All statements and expressions are the sole opinion of WSCF and are subject to change without notice. Information in this release is derived from a variety of sources including that company's publicly disseminated information, third parties and WSCF research. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. WSCF disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. The release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies' discussed in this release is highly speculative and carries a high degree of risk. WSCF is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment if they make a purchase in WSCF profiled stocks.

This profile is not without bias, and is a paid release. WSCF has been compensated for dissemination of company information on behalf of one or more of the companies mentioned in this release. For current services performed for Caleco Pharma Corp. (OTCBB: CAEH), WSCF has been compensated Forty Thousand Dollars, by a third party who is non-affiliated and may hold a significant position in the stock. WSCF holds no shares of the stock. WSCF may receive additional compensation for extension of its services. Any additional compensation will be disclosed at such time that WSCF is aware of a client's desire to extend the original services. WSCF may have received shares of a company profiled in this release prior to the dissemination of the information in this release. WSCF may immediately sell some or any shares in a profiled company held by WSCF and may have previously sold shares in a profiled company held by WSCF. WSCF's services for a company may cause the company's stock price to increase, in which event WSCF would make a profit when it sells its stock in a company. In addition, WSCF's selling of a company's stock may have a negative effect on the market price of the stock.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and WSCF undertakes no obligation to update such statements.

Contact Information